Clinical Trials Directory

Trials / Completed

CompletedNCT05800288

Effect of Midazolam Bolus on Eleveld and Schnider TCI (Target Controlled Infusion) Models

Clinical Comparison Between Two Propofol TCI Models(Eleveld and Schnider) for General Anaesthesia After Premedication With Midazolam

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Padova · Academic / Other
Sex
Female
Age
18 Years – 85 Years
Healthy volunteers

Summary

No trials have evaluated the effect of a Midazolam bolus (routinely used for premedication before general anesthesia) on the Concnetration at the effector site of Propofol (CeP) of Eleveld and Schnider TCI models, routinely used for general anesthesia delivery.

Detailed description

During recent years Eleveld and colleagues ideated a new propofol pharmacokinetic/pharmacodynamic (PK/PD) model for total intravenous anaesthesia with target controlled infusion (TIVA-TCI) pumps that has been proposed to have slightly better predictive performance for measured propofol plasma concentrations compared with those of the Marsh and Schnider models, and suitable for children, adults, older subjects, and obese adults, being considered as a "General purpose" model. However, no trials have compared the Eleveld to the Schnidermodel after a premedication with Midazolam bolus (0.03 mg/kg) from a clinical point of view; so, this study aimed toevaluate midazolam effect on the estimated effector site concentration of the two models (CePE and CePS, respectively) at loss of responsiveness (LoR), during anaesthesia maintenance (Bispectral Index \[BIS\] 40-60) and return of responsiveness (RoR). The study also compared the incidence of deepening or superficializing anaesthesia (defined respectively as lowering or increasing in out-of-target BIS after initial CeP detection), as well as unwanted anaesthesia events: burst suppression (BSupp, identified as a burst suppression ratio \[BSR\] \>0) and unwanted spontaneous responsiveness.

Conditions

Interventions

TypeNameDescription
DRUGPropofolPatients will be observationally included in the Elveld TCI or Schnider TCI group. The TCI model is choosen at anesthesiologist's discreption, as suggested in literature

Timeline

Start date
2023-03-30
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2023-04-05
Last updated
2023-10-19

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05800288. Inclusion in this directory is not an endorsement.